Abstract | BACKGROUND: METHODS: From 06/2004 to 12/2005 39 men were treated by 80 Gy IMRT along with organ tracking. Median age was 69 years, risk of recurrence was low 18%, intermediate 21% and high in 61% patients. Hormone therapy (HT) was received by 74% of patients. Toxicity was scored according to the CTC scale version 3.0. Median follow-up (FU) was 29 months. RESULTS: Acute and maximal late grade 2 gastrointestinal (GI) toxicity was 3% and 8%, late grade 2 GI toxicity dropped to 0% at the end of FU. No acute or late grade 3 GI toxicity was observed. Grade 2 and 3 pre-treatment genitourinary (GU) morbidity (PGUM) was 20% and 5%. Acute and maximal late grade 2 GU toxicity was 56% and 28% and late grade 2 GU toxicity decreased to 15% of patients at the end of FU. Acute and maximal late grade 3 GU toxicity was 8% and 3%, respectively. Decreased late > or = grade 2 GU toxicity free survival was associated with higher age (P = .025), absence of HT (P = .016) and higher PGUM (P < .001). DISCUSSION: GI toxicity rates after IMRT and organ tracking are excellent, GU toxicity rates are strongly related to PGUM.
|
Authors | Pirus Ghadjar, Jacqueline Vock, Daniel Vetterli, Peter Manser, Roland Bigler, Jan Tille, Axel Madlung, Frank Behrensmeier, Roberto Mini, Daniel M Aebersold |
Journal | Radiation oncology (London, England)
(Radiat Oncol)
Vol. 3
Pg. 35
(Oct 20 2008)
ISSN: 1748-717X [Electronic] England |
PMID | 18937833
(Publication Type: Journal Article)
|
Topics |
- Aged
- Aged, 80 and over
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Proportional Hazards Models
- Prostatic Neoplasms
(radiotherapy)
- Radiation Injuries
(etiology)
- Radiotherapy Dosage
- Radiotherapy, Intensity-Modulated
(adverse effects)
- Recurrence
- Risk
- Time Factors
- Treatment Outcome
|